CompletedNCT01354132
Official study titleEffects of Oral N-Acetyl-Cysteine (NAC) in the Early Phase of Schizophrenia Spectrum Psychosis: Randomized, Parallel, Double- Blind, Placebo Controlled Trial
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–35
- Countries
- United States
- Sponsor
- Beth Israel Deaconess Medical Center
CompletedNCT01393600
What is this study about?This study evaluated the safety and effectiveness of NBI-98854 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Neurocrine Biosciences (Biotech company)
CompletedNCT01688037
What is this study about?This study evaluated the safety and effectiveness of NBI-98854 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–85
- Countries
- United States
- Sponsor
- Neurocrine Biosciences (Biotech company)
CompletedNCT03995368
Official study titleNew Applications of Neuroplasticity Biomarkers in Veterans With Traumatic Brain Injury or Schizophrenia
This study has finished and is no longer accepting participants.
In West Los AngelesSchizophreniaInterventional studyAges 25–55
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
CompletedNCT02458924
Official study titleNiacin Skin Flush Response in Patients With Schizophrenia, Their First Degree Relatives, Bipolar Disorder Patients, and Healthy Controls
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaInterventional studyAges 18–65
- Countries
- Sponsor
- Isfahan University of Medical Sciences
CompletedNCT00135772
Official study titleNicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In PiscatawaySchizophrenia, AddictionObservational studyAges 18–70
- Countries
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
Active Not RecruitingNCT06370793
Official study titleNingbo Schizophrenia Cohort, a Longitudinal Population-based Ambispective Cohort Study
This study is no longer accepting new participants.
In NingboSchizophreniaObservational studyAges 18–65
- Countries
- China
- Sponsor
- Ningbo University
CompletedNCT05480046
Official study titleRisperidone ISM® Effectiveness in Schizophrenia Patients Hospitalised Due to A Relapse: a Prospective Non-interventional Evaluation (RESHAPE Study)
This study has finished and is no longer accepting participants.
Multiple locations, including AachenSchizophreniaObservational studyAges 18+
- Countries
- United Kingdom, Germany, Italy, + 2 others
- Sponsor
- Rovi Pharmaceuticals Laboratories
CompletedNCT02230384
Official study titleThe Development of of A Novel Therapeutic to Aid Tobacco Smoking Cessation in Persons With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In PittsburghSchizophreniaMedication studyAges 18–66
- Countries
- United States
- Sponsor
- K.N. Roy Chengappa
CompletedNCT03919994
Official study titleOASIS: Observational Study of LAIs In Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonSchizophreniaObservational studyAges 18+
- Countries
- United States
- Sponsor
- Alkermes, Inc.
CompletedNCT04312503
Official study titleObservational Study on the Effect of Switch to Lurasidone or Other Antipsychothics on Metabolic and Weight Changes in Subjects With Schizophrenia"
This study has finished and is no longer accepting participants.
Multiple locations, including AnconaSchizophreniaObservational studyAges 18+
- Countries
- Italy
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A